Skip to main content

Telix Pharmaceuticals Ltd

TLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002007191

No open-market purchases or sales by Telix Pharmaceuticals Ltd insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $36.6M in total; no superinvestor holds it.

Other share classesTLPPF

Q4 2025 vs. Q3 2025

How the institutions holding Telix Pharmaceuticals Ltd changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of TLX: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders2740+13
Shares823.2K1.12M+298.2K (+36.2%)
Value$7.88M$8.47M+$590.9K (+7.5%)

New holders (17)

Institutions that held Telix Pharmaceuticals Ltd at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to TLX in Q4 2025
InstitutionSharesValue% of portfolio
Quadrature Capital Ltd36,828$275.8K0.00%
Mariner, LLC36,582$274.0K0.00%
Vident Advisory, LLC27,249$204.1K0.00%
Citadel Advisors LLC22,998$172.3K0.00%
Point72 Asset Management, L.P.18,409$137.9K0.00%
Old Mission Capital LLC14,799$110.8K0.00%
XTX Topco Ltd11,820$88.5K0.00%
BNP Paribas Arbitrage, SA1,500$11.2K0.00%
Aspect Partners, LLC352$2.64K0.00%
Basecamp Wealth Advisors LLC276$2.07K0.00%
BlackRock, Inc.88$6590.00%
Smartleaf Asset Management LLC72$5580.00%
Independence Bank of Kentucky66$4940.00%
Cornerstone Financial Management LLC51$3820.00%
Parallel Advisors, LLC12$930.00%
MV Capital Management, Inc.11$830.00%
SageView Advisory Group, LLC2$150.00%

Sold out (4)

Institutions that held Telix Pharmaceuticals Ltd at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of TLX in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
HRT Financial LP11,641$111.0K
State of Wyoming1,293$12.4K
Larson Financial Group LLC53$507
Principal Securities, Inc.21$201